NRG-GY019
A Randomized Phase III, Two-Arm Trial of Paclitaxel/Carboplatin/Maintenance Letrozole Versus Letrozole Monotherapy in Patients with Stage II-IV, Primary Low-Grade Serous Carcinoma of the Ovary or Peritoneum
Description: This trial assesses the effectiveness of 2 treatments ,Paclitaxel/Carboplatin/Maintenance Letrozole combination v's Letrozole Monotherapy in patients with Stage II-IV Primary Low-Grade Serous Carcinoma of the Ovary or Peritoneum.
Study Phase: Phase 3
Principal Investigator: Prof Karen Cadoo
Further information
